Home › Knowledge Hub › Damp, mould and aspergillosis › Health effects
This page explains what damp and mould can do to the lungs and how to recognise patterns that suggest your home is contributing to symptoms.
How damp buildings can affect the lungs
Damp homes can increase exposure to airborne particles including fungal spores and fragments. For many people this causes irritation; for people with chronic lung disease it can trigger significant exacerbations.
- Worsening cough, wheeze, breathlessness
- Increased mucus and reduced airway clearance
- More frequent chest infections / antibiotic courses
- Allergic-type reactions in sensitised individuals
Why aspergillosis and severe airways disease are different
If you have Aspergillus-related disease or severe asthma/bronchiectasis, your airways may react strongly to fungal material and irritants. Some patients also require systemic or inhaled corticosteroids, which can increase susceptibility to infections and complicate symptom control.
Important nuance: a damp home does not automatically “cause” aspergillosis, but it can be a powerful driver of persistent symptoms and repeated flares.
Patterns that support a housing contribution
- Time-and-place pattern: symptoms worsen at home and improve when away (even partially).
- Multi-person effects: more than one household member develops respiratory/allergic symptoms.
- Post-disturbance worsening: symptoms worsen after “repairs” or “remediation”.
- Escalating medication use: increased reliever inhaler/nebuliser use, repeated steroid bursts, more antibiotics.
Simple symptom timeline template (copy/paste)
Keeping a short, factual timeline helps clinicians and councils understand risk.
Date(s): Where damp/mould is present: What changed (rain event, leak, repair work, return after decant): Symptoms (breathlessness/wheeze/cough/fever/skin/eyes/nose): Medication change (inhalers, steroids, antibiotics): Healthcare use (GP/A&E/hospital): Improves when away from home? (yes/no, how quickly):
What to ask your clinician to document
- Diagnosis (e.g., Chronic pulmonary aspergillosis, allergic bronchopulmonary aspergillosis, asthma, bronchiectasis)
- That symptoms are consistent with environmental triggers or worsened by damp/mould exposure (they do not need to prove causation)
- Any vulnerability factors (steroid use, immunosuppression, reduced lung function)
Share this post
Latest News posts
COVID Vaccination Side Effects
April 26, 2021
How to manage breathlessness
April 23, 2021
Indoor Air Quality at Home (NHS guidelines )
April 12, 2021
Aspergillosis monthly patient & carer meeting
April 7, 2021
COVID Vaccination – hesitating?
February 24, 2021
What is an MDT?
February 17, 2021
Aspergillosis Monthly Patient & Carer Meeting
February 5, 2021
World Aspergillosis Day 2021
February 2, 2021
World Aspergillosis Day, 1 February 2021
January 28, 2021
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
